GRAINGER DAVID J 4
4 · Centessa Pharmaceuticals plc · Filed Nov 2, 2021
Insider Transaction Report
Form 4
GRAINGER DAVID J
Chief Innovation Officer
Transactions
- Award
Share Option (right to buy)
2021-11-01+175,000→ 175,000 totalExercise: $14.01Exp: 2031-11-01→ Ordinary Shares (175,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on November 1, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.